Showing 811-820 of 1043 results for "".
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN1005DementiaInsights-pdf/31386/Medicare’s Limited Approval of PET Scans in Dementia: Implications for Clinical PracticeIn September 2004, the Centers for Medicare and Medicaid Services (CMS) approved the use of positron emission tomography (PET) scans for dementia diagnosis, specifically to differentiate Alzheimer’s disease (AD)
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31420/Advancements in Alzheimer’s Disease Research Highlight Potential Therapeutic BreakthroughsAs Practical Neurology commemorates the 99th anniversary of Alois Alzheimer’s seminal work, recent studies offer promising avenues for combating Alzheimer’s disease (AD). Despite the absence of a cure, signific
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0705dementia-pdf/31426/
- Epilepsy Care: Can We Succeed with Monotherapy?https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0405CvrStry-pdf/31461/Advancements and Challenges in Antiepileptic Drug MonotherapyIn the realm of epilepsy management, achieving seizure freedom remains the primary goal for neurologists and patients alike. Approximately 60-70% of newly diagnosed epilepsy patients achieve control with a single antiepileptic drug (AED),
- Bringing Chronic Daily Headache Into Focushttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0305FeaChronicHeadache-pdf/31481/Updates to IHS Headache Classification: Implications for Clinical PracticeThe International Headache Society (IHS) recently updated its classification of chronic daily headache (CDH), presenting significant changes that impact neurologists and headache specialists. Published in *Cephalalgia* in 2004
- Bringing in the Bucks with Botoxhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0205pg37-40-pdf/31492/Botulinum toxin A (Botox), since its FDA approval in 1989, has become a valuable tool for neurologists, enhancing patient care while contributing to practice revenue. Its approved uses include treating cervical dystonia, intractable migraines, facial nerve disorders, spasmodic dysphonia, hyperhidros
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0205pg59-60-pdf/31494/Optimizing Antiseizure Medication Selection in Epilepsy ManagementThe terminology surrounding epilepsy treatment is evolving, with increasing advocacy for the term “anti-seizure drugs” (ASDs) over the traditional “antiepileptic drugs” (AEDs). This shift emphasizes the role of these medications in su
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31498/Implementing Strategic Plans in Neurology Practices: Essential Financial Tools for SuccessDeveloping a strategic plan is a critical step for neurology practices aiming to achieve long-term success. However, the true challenge lies not just in creating the plan but in effectively implementing it. A c
- Putting the “New” Stroke Triggers in Contexthttps://practicalneurology.com/diseases-diagnoses/stroke/0105-vascularclinic-pdf/31508/Recent advancements in stroke prevention following transient ischemic attacks (TIA) have been highlighted in the June 2008 issue of *Practical Neurology*. Two significant studies, EXPRESS and SOS-TIA, provide compelling evidence that rapid intervention can substantially reduce the risk of subsequent
- 52 Improvements That Will Revitalize Your Practice in 2005https://practicalneurology.com/columns/practice-management/52-improvements-that-will-revitalize-your-practice-in-2005/31499/Effective practice management is crucial for neurologists aiming to enhance both financial performance and patient care. The January to December 2005 edition of Practical Neurology offers a comprehensive 52-week guide with actionable strategies tailored for neurology practices.Benchmarking and Finan